Life sciences stories
The consultancy is betting on growing demand for better use of planning software as companies seek tighter inventory control and more reliable forecasting.
QuEra survey finds quantum buyers and backers are demanding stronger proof of value, even as 46% of organisations expect budgets to stay flat.
AI in life sciences is boosting workflows rather than replacing scientists, as firms navigate regulation, data risks and uneven adoption across markets.
Life sciences firms could avoid costly FDA review delays as the software flags conflicting claims across filings before submissions are sent.
The new tools give life sciences finance teams clearer trial spending forecasts and scenario planning after a USD $24 million Series A round.
The range is set to reach pharmacy shelves next month, as EZZ seeks to tap demand for evidence-backed women’s wellness products.
Bookings surged 21% in the first quarter, prompting Cognizant to raise its adjusted operating margin outlook and back annual revenue guidance.
Business users could get governed AI support inside analytics workflows as SAS adds copilots, agents and open-standard connectors to Viya.
The drugmaker plans to spread AI across 75,000 staff, from research to manufacturing, as it seeks faster launches and leaner operations.
Early adopters are seeing stronger returns as AI agents move from trials into core operations across customer service, security and support.
Healthtech startups are finding it harder to scale as weaker exits and tighter liquidity help drive Canadian VC investment down to CAD $1 billion in 2025.
Yet only 15 per cent have deployed OT-specific visibility tools, even as cyber incidents have already disrupted critical systems for most respondents.
The AUD $490 million Waterloo precinct is set to ease Sydney’s lab space shortage as it moves into delivery with major global partners.
The funding could help turn hospital infusions into self-injectable treatments, as the London-founded firm scales microgravity drug crystallisation.
AI adoption is pushing firms to use external support to bridge skills gaps, modernise systems and reduce cyber risk as projects move into production.
Federal buyers of AI and HPC systems will gain wider access to Cornelis’s CN5000 platform through new partners ASI Corp, CTG Federal and TVAR Solutions.
Canada’s health tech sector is struggling to turn strong research into commercial scale, as panellists split over whether policy or private capital should lead.
As India’s AI boom accelerates, investors are being urged to weigh trust, inclusion and long-term value alongside growth and scale.
A state-backed push to fund northern university spinouts has lifted Northern Gritstone’s capital base to GBP £382 million amid a tough fundraising market.
The five-year deal will give Swedish researchers and smaller firms cloud-style access to AI infrastructure as demand for Mimer grows.
